nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—UGT2B7—Epirubicin—ovarian cancer	0.315	0.634	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Topotecan—ovarian cancer	0.0644	0.13	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Vinorelbine—ovarian cancer	0.0453	0.0914	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Paclitaxel—ovarian cancer	0.0319	0.0642	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Docetaxel—ovarian cancer	0.023	0.0464	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Doxorubicin—ovarian cancer	0.0172	0.0346	CbGbCtD
Chenodeoxycholic acid—CYP27A1—myometrium—ovarian cancer	0.00673	0.114	CbGeAlD
Chenodeoxycholic acid—NR1H4—female reproductive system—ovarian cancer	0.00539	0.0916	CbGeAlD
Chenodeoxycholic acid—CYP27A1—uterine cervix—ovarian cancer	0.00524	0.089	CbGeAlD
Chenodeoxycholic acid—CYP27A1—decidua—ovarian cancer	0.00499	0.0848	CbGeAlD
Chenodeoxycholic acid—NR1H4—female gonad—ovarian cancer	0.0049	0.0833	CbGeAlD
Chenodeoxycholic acid—CYP27A1—endometrium—ovarian cancer	0.00474	0.0805	CbGeAlD
Chenodeoxycholic acid—CYP27A1—female reproductive system—ovarian cancer	0.00392	0.0667	CbGeAlD
Chenodeoxycholic acid—CYP27A1—female gonad—ovarian cancer	0.00357	0.0607	CbGeAlD
Chenodeoxycholic acid—CYP27A1—vagina—ovarian cancer	0.00355	0.0603	CbGeAlD
Chenodeoxycholic acid—UGT2B7—female reproductive system—ovarian cancer	0.00347	0.059	CbGeAlD
Chenodeoxycholic acid—CYP27A1—testis—ovarian cancer	0.00317	0.0538	CbGeAlD
Chenodeoxycholic acid—NR1H4—lymph node—ovarian cancer	0.00315	0.0536	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Endogenous sterols—CYP1B1—ovarian cancer	0.00297	0.0618	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—testis—ovarian cancer	0.0028	0.0476	CbGeAlD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00271	0.0564	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.00259	0.054	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—lymph node—ovarian cancer	0.0023	0.039	CbGeAlD
Chenodeoxycholic acid—NR1H4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.00227	0.0474	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Endogenous sterols—CYP1B1—ovarian cancer	0.00217	0.0452	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Estrogen metabolism—CYP1B1—ovarian cancer	0.00164	0.0342	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00145	0.0303	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00138	0.0287	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00136	0.0283	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00135	0.0281	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00131	0.0272	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00112	0.0233	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Orphan transporters—TUBB3—ovarian cancer	0.00105	0.0219	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00101	0.021	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—female reproductive system—ovarian cancer	0.000946	0.0161	CbGeAlD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—YAP1—ovarian cancer	0.000835	0.0174	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—ovarian cancer	0.000818	0.017	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000817	0.017	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.00072	0.015	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.000664	0.0138	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.000658	0.0137	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000595	0.0124	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—CYP1B1—ovarian cancer	0.000594	0.0124	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000585	0.0122	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—ovarian cancer	0.000563	0.0117	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NR5A1—ovarian cancer	0.000468	0.00974	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—ovarian cancer	0.000459	0.00956	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000458	0.00953	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP1B1—ovarian cancer	0.000434	0.00903	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.000378	0.00787	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NME2—ovarian cancer	0.000362	0.00754	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000338	0.00704	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000334	0.00696	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000334	0.00695	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—SLC5A5—ovarian cancer	0.000333	0.00693	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000326	0.00678	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000324	0.00675	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—SLC2A1—ovarian cancer	0.000321	0.00669	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—WDR77—ovarian cancer	0.000316	0.00658	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000307	0.00639	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.000274	0.00571	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP1B1—ovarian cancer	0.00027	0.00563	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—YAP1—ovarian cancer	0.000267	0.00556	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000267	0.00555	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NME2—ovarian cancer	0.000264	0.00551	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000256	0.00534	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00025	0.00521	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—TTF1—ovarian cancer	0.000248	0.00517	CbGpPWpGaD
Chenodeoxycholic acid—Infestation NOS—Epirubicin—ovarian cancer	0.00024	0.000606	CcSEcCtD
Chenodeoxycholic acid—Infestation—Epirubicin—ovarian cancer	0.00024	0.000606	CcSEcCtD
Chenodeoxycholic acid—Bronchitis—Doxorubicin—ovarian cancer	0.00024	0.000605	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Paclitaxel—ovarian cancer	0.000239	0.000603	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Paclitaxel—ovarian cancer	0.000238	0.000601	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Docetaxel—ovarian cancer	0.000237	0.000598	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Docetaxel—ovarian cancer	0.000237	0.000598	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Docetaxel—ovarian cancer	0.000237	0.000598	CcSEcCtD
Chenodeoxycholic acid—Nausea—Vinorelbine—ovarian cancer	0.000237	0.000597	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Epirubicin—ovarian cancer	0.000236	0.000596	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Paclitaxel—ovarian cancer	0.000236	0.000595	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000235	0.000594	CcSEcCtD
Chenodeoxycholic acid—Jaundice—Epirubicin—ovarian cancer	0.000234	0.000591	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Epirubicin—ovarian cancer	0.000234	0.000589	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Epirubicin—ovarian cancer	0.000234	0.000589	CcSEcCtD
Chenodeoxycholic acid—Dysuria—Doxorubicin—ovarian cancer	0.000233	0.000588	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYTB—ovarian cancer	0.000233	0.00486	CbGpPWpGaD
Chenodeoxycholic acid—Decreased appetite—Paclitaxel—ovarian cancer	0.000233	0.000588	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—PGR—ovarian cancer	0.000233	0.00485	CbGpPWpGaD
Chenodeoxycholic acid—Dry mouth—Docetaxel—ovarian cancer	0.000232	0.000584	CcSEcCtD
Chenodeoxycholic acid—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000232	0.000584	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000232	0.000584	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Paclitaxel—ovarian cancer	0.000231	0.000583	CcSEcCtD
Chenodeoxycholic acid—Sweating—Epirubicin—ovarian cancer	0.00023	0.000581	CcSEcCtD
Chenodeoxycholic acid—Pollakiuria—Doxorubicin—ovarian cancer	0.00023	0.000581	CcSEcCtD
Chenodeoxycholic acid—Pain—Paclitaxel—ovarian cancer	0.000229	0.000578	CcSEcCtD
Chenodeoxycholic acid—Constipation—Paclitaxel—ovarian cancer	0.000229	0.000578	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Epirubicin—ovarian cancer	0.000229	0.000578	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Docetaxel—ovarian cancer	0.000229	0.000578	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000228	0.00475	CbGpPWpGaD
Chenodeoxycholic acid—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000228	0.000574	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000227	0.000573	CcSEcCtD
Chenodeoxycholic acid—Oedema—Docetaxel—ovarian cancer	0.000227	0.000573	CcSEcCtD
Chenodeoxycholic acid—Weight increased—Doxorubicin—ovarian cancer	0.000227	0.000572	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Epirubicin—ovarian cancer	0.000227	0.000571	CcSEcCtD
Chenodeoxycholic acid—Infection—Docetaxel—ovarian cancer	0.000226	0.000569	CcSEcCtD
Chenodeoxycholic acid—Weight decreased—Doxorubicin—ovarian cancer	0.000226	0.000569	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Epirubicin—ovarian cancer	0.000226	0.000568	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—NR5A1—ovarian cancer	0.000225	0.00469	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000224	0.00467	CbGpPWpGaD
Chenodeoxycholic acid—Pneumonia—Doxorubicin—ovarian cancer	0.000224	0.000564	CcSEcCtD
Chenodeoxycholic acid—Shock—Docetaxel—ovarian cancer	0.000224	0.000564	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Docetaxel—ovarian cancer	0.000223	0.000562	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Docetaxel—ovarian cancer	0.000223	0.000561	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Doxorubicin—ovarian cancer	0.000222	0.000561	CcSEcCtD
Chenodeoxycholic acid—Infestation—Doxorubicin—ovarian cancer	0.000222	0.000561	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Docetaxel—ovarian cancer	0.000222	0.000559	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Paclitaxel—ovarian cancer	0.000221	0.000557	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Docetaxel—ovarian cancer	0.000221	0.000556	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000219	0.000553	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Doxorubicin—ovarian cancer	0.000219	0.000551	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Epirubicin—ovarian cancer	0.000217	0.000547	CcSEcCtD
Chenodeoxycholic acid—Jaundice—Doxorubicin—ovarian cancer	0.000217	0.000546	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Docetaxel—ovarian cancer	0.000217	0.000546	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—PARP1—ovarian cancer	0.000217	0.00451	CbGpPWpGaD
Chenodeoxycholic acid—Rhinitis—Epirubicin—ovarian cancer	0.000216	0.000545	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Doxorubicin—ovarian cancer	0.000216	0.000545	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Doxorubicin—ovarian cancer	0.000216	0.000545	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Epirubicin—ovarian cancer	0.000216	0.000544	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Epirubicin—ovarian cancer	0.000214	0.00054	CcSEcCtD
Chenodeoxycholic acid—Sweating—Doxorubicin—ovarian cancer	0.000213	0.000537	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Epirubicin—ovarian cancer	0.000213	0.000537	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Paclitaxel—ovarian cancer	0.000213	0.000537	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Epirubicin—ovarian cancer	0.000213	0.000536	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Docetaxel—ovarian cancer	0.000212	0.000535	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Doxorubicin—ovarian cancer	0.000212	0.000535	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Epirubicin—ovarian cancer	0.000212	0.000534	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Paclitaxel—ovarian cancer	0.000212	0.000534	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Paclitaxel—ovarian cancer	0.000212	0.000534	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Epirubicin—ovarian cancer	0.000212	0.000533	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00021	0.00053	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Doxorubicin—ovarian cancer	0.00021	0.000529	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Doxorubicin—ovarian cancer	0.000209	0.000526	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Epirubicin—ovarian cancer	0.000208	0.000524	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000207	0.000522	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Docetaxel—ovarian cancer	0.000206	0.000518	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Docetaxel—ovarian cancer	0.000204	0.000514	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—BRIP1—ovarian cancer	0.000204	0.00424	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PPP1CC—ovarian cancer	0.000204	0.00424	CbGpPWpGaD
Chenodeoxycholic acid—Dyspnoea—Docetaxel—ovarian cancer	0.000203	0.000511	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Docetaxel—ovarian cancer	0.000202	0.000509	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Epirubicin—ovarian cancer	0.000202	0.000508	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Epirubicin—ovarian cancer	0.000201	0.000507	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Doxorubicin—ovarian cancer	0.000201	0.000506	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Epirubicin—ovarian cancer	0.0002	0.000505	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Doxorubicin—ovarian cancer	0.0002	0.000505	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Docetaxel—ovarian cancer	0.0002	0.000504	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Doxorubicin—ovarian cancer	0.0002	0.000503	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Doxorubicin—ovarian cancer	0.000198	0.000499	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Docetaxel—ovarian cancer	0.000198	0.000498	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Paclitaxel—ovarian cancer	0.000198	0.000498	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000197	0.000497	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Doxorubicin—ovarian cancer	0.000197	0.000496	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000196	0.00409	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000196	0.000495	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000196	0.000495	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Docetaxel—ovarian cancer	0.000196	0.000494	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Epirubicin—ovarian cancer	0.000196	0.000493	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Doxorubicin—ovarian cancer	0.000196	0.000493	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Epirubicin—ovarian cancer	0.000195	0.000491	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Epirubicin—ovarian cancer	0.000194	0.00049	CcSEcCtD
Chenodeoxycholic acid—Constipation—Docetaxel—ovarian cancer	0.000194	0.00049	CcSEcCtD
Chenodeoxycholic acid—Pain—Docetaxel—ovarian cancer	0.000194	0.00049	CcSEcCtD
Chenodeoxycholic acid—Chills—Epirubicin—ovarian cancer	0.000194	0.000488	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Epirubicin—ovarian cancer	0.000193	0.000486	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Doxorubicin—ovarian cancer	0.000192	0.000485	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Paclitaxel—ovarian cancer	0.000192	0.000485	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Epirubicin—ovarian cancer	0.000191	0.000481	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Paclitaxel—ovarian cancer	0.00019	0.000478	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Epirubicin—ovarian cancer	0.000188	0.000473	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Docetaxel—ovarian cancer	0.000187	0.000472	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000187	0.00389	CbGpPWpGaD
Chenodeoxycholic acid—Eye disorder—Doxorubicin—ovarian cancer	0.000187	0.00047	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Doxorubicin—ovarian cancer	0.000186	0.000469	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000186	0.000468	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Doxorubicin—ovarian cancer	0.000185	0.000467	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Epirubicin—ovarian cancer	0.000185	0.000467	CcSEcCtD
Chenodeoxycholic acid—Tension—Epirubicin—ovarian cancer	0.000184	0.000465	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Paclitaxel—ovarian cancer	0.000183	0.000462	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000183	0.00381	CbGpPWpGaD
Chenodeoxycholic acid—Nervousness—Epirubicin—ovarian cancer	0.000182	0.00046	CcSEcCtD
Chenodeoxycholic acid—Back pain—Epirubicin—ovarian cancer	0.000182	0.000458	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Doxorubicin—ovarian cancer	0.000181	0.000457	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Epirubicin—ovarian cancer	0.000181	0.000455	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Doxorubicin—ovarian cancer	0.00018	0.000455	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00018	0.000454	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Docetaxel—ovarian cancer	0.00018	0.000453	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Docetaxel—ovarian cancer	0.00018	0.000453	CcSEcCtD
Chenodeoxycholic acid—Chills—Doxorubicin—ovarian cancer	0.000179	0.000452	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Doxorubicin—ovarian cancer	0.000178	0.00045	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000178	0.00371	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Paclitaxel—ovarian cancer	0.000177	0.000447	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Doxorubicin—ovarian cancer	0.000176	0.000445	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Epirubicin—ovarian cancer	0.000174	0.000439	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Doxorubicin—ovarian cancer	0.000174	0.000438	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Epirubicin—ovarian cancer	0.000174	0.000438	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Doxorubicin—ovarian cancer	0.000171	0.000432	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000171	0.00356	CbGpPWpGaD
Chenodeoxycholic acid—Tension—Doxorubicin—ovarian cancer	0.000171	0.00043	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Paclitaxel—ovarian cancer	0.000171	0.00043	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CYTB—ovarian cancer	0.00017	0.00355	CbGpPWpGaD
Chenodeoxycholic acid—Malaise—Epirubicin—ovarian cancer	0.000169	0.000427	CcSEcCtD
Chenodeoxycholic acid—Rash—Paclitaxel—ovarian cancer	0.000169	0.000426	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Paclitaxel—ovarian cancer	0.000169	0.000426	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Doxorubicin—ovarian cancer	0.000169	0.000425	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Epirubicin—ovarian cancer	0.000169	0.000425	CcSEcCtD
Chenodeoxycholic acid—Syncope—Epirubicin—ovarian cancer	0.000168	0.000425	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Epirubicin—ovarian cancer	0.000168	0.000424	CcSEcCtD
Chenodeoxycholic acid—Back pain—Doxorubicin—ovarian cancer	0.000168	0.000424	CcSEcCtD
Chenodeoxycholic acid—Headache—Paclitaxel—ovarian cancer	0.000168	0.000423	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Docetaxel—ovarian cancer	0.000167	0.000422	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Doxorubicin—ovarian cancer	0.000167	0.000421	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000167	0.00347	CbGpPWpGaD
Chenodeoxycholic acid—Palpitations—Epirubicin—ovarian cancer	0.000166	0.000418	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000165	0.00344	CbGpPWpGaD
Chenodeoxycholic acid—Loss of consciousness—Epirubicin—ovarian cancer	0.000165	0.000416	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—NME2—ovarian cancer	0.000165	0.00343	CbGpPWpGaD
Chenodeoxycholic acid—Cough—Epirubicin—ovarian cancer	0.000164	0.000413	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Docetaxel—ovarian cancer	0.000163	0.000411	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Epirubicin—ovarian cancer	0.000163	0.00041	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Epirubicin—ovarian cancer	0.000162	0.000409	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000161	0.000406	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Docetaxel—ovarian cancer	0.000161	0.000405	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Doxorubicin—ovarian cancer	0.000161	0.000405	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Epirubicin—ovarian cancer	0.00016	0.000403	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Epirubicin—ovarian cancer	0.00016	0.000403	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Epirubicin—ovarian cancer	0.00016	0.000403	CcSEcCtD
Chenodeoxycholic acid—Nausea—Paclitaxel—ovarian cancer	0.000159	0.000401	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000159	0.0004	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Epirubicin—ovarian cancer	0.000158	0.000398	CcSEcCtD
Chenodeoxycholic acid—Malaise—Doxorubicin—ovarian cancer	0.000157	0.000395	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Epirubicin—ovarian cancer	0.000156	0.000394	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Doxorubicin—ovarian cancer	0.000156	0.000394	CcSEcCtD
Chenodeoxycholic acid—Syncope—Doxorubicin—ovarian cancer	0.000156	0.000393	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Doxorubicin—ovarian cancer	0.000156	0.000392	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Docetaxel—ovarian cancer	0.000156	0.000392	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Epirubicin—ovarian cancer	0.000155	0.00039	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Doxorubicin—ovarian cancer	0.000154	0.000387	CcSEcCtD
Chenodeoxycholic acid—Oedema—Epirubicin—ovarian cancer	0.000153	0.000386	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Doxorubicin—ovarian cancer	0.000153	0.000385	CcSEcCtD
Chenodeoxycholic acid—Infection—Epirubicin—ovarian cancer	0.000152	0.000384	CcSEcCtD
Chenodeoxycholic acid—Cough—Doxorubicin—ovarian cancer	0.000152	0.000382	CcSEcCtD
Chenodeoxycholic acid—Shock—Epirubicin—ovarian cancer	0.000151	0.00038	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Doxorubicin—ovarian cancer	0.000151	0.00038	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Epirubicin—ovarian cancer	0.00015	0.000379	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Docetaxel—ovarian cancer	0.00015	0.000379	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Epirubicin—ovarian cancer	0.00015	0.000378	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Doxorubicin—ovarian cancer	0.00015	0.000378	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Epirubicin—ovarian cancer	0.00015	0.000377	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—PPP1CC—ovarian cancer	0.000149	0.0031	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—BRIP1—ovarian cancer	0.000149	0.0031	CbGpPWpGaD
Chenodeoxycholic acid—Skin disorder—Epirubicin—ovarian cancer	0.000149	0.000375	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000149	0.00309	CbGpPWpGaD
Chenodeoxycholic acid—Hyperhidrosis—Epirubicin—ovarian cancer	0.000148	0.000374	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Doxorubicin—ovarian cancer	0.000148	0.000373	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Doxorubicin—ovarian cancer	0.000148	0.000373	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Doxorubicin—ovarian cancer	0.000148	0.000373	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000147	0.00037	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Doxorubicin—ovarian cancer	0.000146	0.000369	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Epirubicin—ovarian cancer	0.000146	0.000368	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Doxorubicin—ovarian cancer	0.000145	0.000365	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Docetaxel—ovarian cancer	0.000145	0.000364	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000144	0.003	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Docetaxel—ovarian cancer	0.000143	0.000361	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Epirubicin—ovarian cancer	0.000143	0.000361	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Docetaxel—ovarian cancer	0.000143	0.000361	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Doxorubicin—ovarian cancer	0.000143	0.000361	CcSEcCtD
Chenodeoxycholic acid—Headache—Docetaxel—ovarian cancer	0.000142	0.000359	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000142	0.00296	CbGpPWpGaD
Chenodeoxycholic acid—Oedema—Doxorubicin—ovarian cancer	0.000142	0.000358	CcSEcCtD
Chenodeoxycholic acid—Infection—Doxorubicin—ovarian cancer	0.000141	0.000355	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00014	0.000352	CcSEcCtD
Chenodeoxycholic acid—Shock—Doxorubicin—ovarian cancer	0.00014	0.000352	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Doxorubicin—ovarian cancer	0.000139	0.000351	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000139	0.00035	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Epirubicin—ovarian cancer	0.000139	0.000349	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Doxorubicin—ovarian cancer	0.000138	0.000349	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Doxorubicin—ovarian cancer	0.000138	0.000347	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Epirubicin—ovarian cancer	0.000138	0.000347	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000137	0.000346	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—YAP1—ovarian cancer	0.000137	0.00285	CbGpPWpGaD
Chenodeoxycholic acid—Dyspnoea—Epirubicin—ovarian cancer	0.000137	0.000345	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Epirubicin—ovarian cancer	0.000136	0.000344	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000135	0.00282	CbGpPWpGaD
Chenodeoxycholic acid—Anorexia—Doxorubicin—ovarian cancer	0.000135	0.000341	CcSEcCtD
Chenodeoxycholic acid—Nausea—Docetaxel—ovarian cancer	0.000135	0.00034	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Epirubicin—ovarian cancer	0.000135	0.00034	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Epirubicin—ovarian cancer	0.000133	0.000336	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Doxorubicin—ovarian cancer	0.000133	0.000334	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000132	0.000334	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Epirubicin—ovarian cancer	0.000132	0.000333	CcSEcCtD
Chenodeoxycholic acid—Pain—Epirubicin—ovarian cancer	0.000131	0.00033	CcSEcCtD
Chenodeoxycholic acid—Constipation—Epirubicin—ovarian cancer	0.000131	0.00033	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00013	0.00272	CbGpPWpGaD
Chenodeoxycholic acid—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000129	0.000326	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—YAP1—ovarian cancer	0.000128	0.00268	CbGpPWpGaD
Chenodeoxycholic acid—Insomnia—Doxorubicin—ovarian cancer	0.000128	0.000323	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Doxorubicin—ovarian cancer	0.000127	0.000321	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Doxorubicin—ovarian cancer	0.000126	0.000319	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Epirubicin—ovarian cancer	0.000126	0.000318	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Doxorubicin—ovarian cancer	0.000126	0.000318	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000125	0.000316	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Doxorubicin—ovarian cancer	0.000125	0.000315	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—ESR1—ovarian cancer	0.000124	0.00259	CbGpPWpGaD
Chenodeoxycholic acid—Decreased appetite—Doxorubicin—ovarian cancer	0.000123	0.000311	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000122	0.000309	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Doxorubicin—ovarian cancer	0.000122	0.000308	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Epirubicin—ovarian cancer	0.000122	0.000307	CcSEcCtD
Chenodeoxycholic acid—Pain—Doxorubicin—ovarian cancer	0.000121	0.000306	CcSEcCtD
Chenodeoxycholic acid—Constipation—Doxorubicin—ovarian cancer	0.000121	0.000306	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Epirubicin—ovarian cancer	0.000121	0.000305	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Epirubicin—ovarian cancer	0.000121	0.000305	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000119	0.00248	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Doxorubicin—ovarian cancer	0.000117	0.000295	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000117	0.00243	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000116	0.000292	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Epirubicin—ovarian cancer	0.000113	0.000285	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Doxorubicin—ovarian cancer	0.000113	0.000284	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—PGR—ovarian cancer	0.000112	0.00234	CbGpPWpGaD
Chenodeoxycholic acid—Body temperature increased—Doxorubicin—ovarian cancer	0.000112	0.000283	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Doxorubicin—ovarian cancer	0.000112	0.000283	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—FASN—ovarian cancer	0.000111	0.00232	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Epirubicin—ovarian cancer	0.00011	0.000277	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—SLC5A5—ovarian cancer	0.00011	0.00228	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000109	0.00226	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Epirubicin—ovarian cancer	0.000108	0.000273	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYTB—ovarian cancer	0.000106	0.00221	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—SLC2A1—ovarian cancer	0.000106	0.0022	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Epirubicin—ovarian cancer	0.000105	0.000264	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Doxorubicin—ovarian cancer	0.000105	0.000263	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—PARP1—ovarian cancer	0.000104	0.00217	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000104	0.00216	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Doxorubicin—ovarian cancer	0.000102	0.000257	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP1B1—ovarian cancer	0.000102	0.00211	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Epirubicin—ovarian cancer	0.000101	0.000256	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Doxorubicin—ovarian cancer	0.0001	0.000253	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—YAP1—ovarian cancer	9.99e-05	0.00208	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.89e-05	0.00206	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Epirubicin—ovarian cancer	9.75e-05	0.000246	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Doxorubicin—ovarian cancer	9.71e-05	0.000245	CcSEcCtD
Chenodeoxycholic acid—Rash—Epirubicin—ovarian cancer	9.67e-05	0.000244	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Epirubicin—ovarian cancer	9.66e-05	0.000243	CcSEcCtD
Chenodeoxycholic acid—Headache—Epirubicin—ovarian cancer	9.6e-05	0.000242	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Doxorubicin—ovarian cancer	9.38e-05	0.000236	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—BRIP1—ovarian cancer	9.28e-05	0.00193	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PPP1CC—ovarian cancer	9.28e-05	0.00193	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Epirubicin—ovarian cancer	9.11e-05	0.00023	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Doxorubicin—ovarian cancer	9.02e-05	0.000227	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—PPP2R1A—ovarian cancer	9e-05	0.00187	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.96e-05	0.00187	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Doxorubicin—ovarian cancer	8.94e-05	0.000225	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Doxorubicin—ovarian cancer	8.94e-05	0.000225	CcSEcCtD
Chenodeoxycholic acid—Headache—Doxorubicin—ovarian cancer	8.89e-05	0.000224	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.69e-05	0.00181	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PPP2R1A—ovarian cancer	8.46e-05	0.00176	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Doxorubicin—ovarian cancer	8.43e-05	0.000212	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ABCB1—ovarian cancer	8.36e-05	0.00174	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—TYMS—ovarian cancer	8.21e-05	0.00171	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—FASN—ovarian cancer	8.14e-05	0.0017	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC5A5—ovarian cancer	8.01e-05	0.00167	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC2A1—ovarian cancer	7.74e-05	0.00161	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.58e-05	0.00158	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP1B1—ovarian cancer	7.42e-05	0.00154	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CAV1—ovarian cancer	6.61e-05	0.00138	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PPP2R1A—ovarian cancer	6.58e-05	0.00137	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.55e-05	0.00136	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—ovarian cancer	6.47e-05	0.00135	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.32e-05	0.00132	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—YAP1—ovarian cancer	6.23e-05	0.0013	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	6.21e-05	0.00129	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	6.12e-05	0.00128	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ABCB1—ovarian cancer	6.11e-05	0.00127	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CG—ovarian cancer	6.03e-05	0.00125	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—TYMS—ovarian cancer	6e-05	0.00125	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—ESR1—ovarian cancer	5.99e-05	0.00125	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CD—ovarian cancer	5.3e-05	0.0011	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—FASN—ovarian cancer	5.08e-05	0.00106	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC5A5—ovarian cancer	4.99e-05	0.00104	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CAV1—ovarian cancer	4.83e-05	0.00101	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC2A1—ovarian cancer	4.82e-05	0.001	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP1B1—ovarian cancer	4.62e-05	0.000963	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.62e-05	0.000962	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CB—ovarian cancer	4.62e-05	0.000961	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CG—ovarian cancer	4.4e-05	0.000917	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PPP2R1A—ovarian cancer	4.1e-05	0.000854	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTEN—ovarian cancer	3.99e-05	0.000831	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CD—ovarian cancer	3.87e-05	0.000806	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ABCB1—ovarian cancer	3.81e-05	0.000793	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NME2—ovarian cancer	3.79e-05	0.000788	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—TYMS—ovarian cancer	3.74e-05	0.000779	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CB—ovarian cancer	3.37e-05	0.000703	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MAPK3—ovarian cancer	3.2e-05	0.000667	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MYC—ovarian cancer	3.12e-05	0.000649	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CAV1—ovarian cancer	3.01e-05	0.000627	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTEN—ovarian cancer	2.92e-05	0.000607	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CA—ovarian cancer	2.81e-05	0.000586	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CG—ovarian cancer	2.74e-05	0.000571	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYTB—ovarian cancer	2.44e-05	0.000508	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CD—ovarian cancer	2.41e-05	0.000502	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—AKT1—ovarian cancer	2.3e-05	0.000479	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—AKT1—ovarian cancer	2.16e-05	0.00045	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.13e-05	0.000444	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.13e-05	0.000444	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CB—ovarian cancer	2.1e-05	0.000438	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CA—ovarian cancer	2.06e-05	0.000428	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTEN—ovarian cancer	1.82e-05	0.000378	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—AKT1—ovarian cancer	1.68e-05	0.00035	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—YAP1—ovarian cancer	1.43e-05	0.000298	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CA—ovarian cancer	1.28e-05	0.000267	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—FASN—ovarian cancer	1.17e-05	0.000243	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.15e-05	0.000239	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.11e-05	0.000231	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.06e-05	0.000221	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—AKT1—ovarian cancer	1.05e-05	0.000218	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	9.42e-06	0.000196	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ABCB1—ovarian cancer	8.74e-06	0.000182	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TYMS—ovarian cancer	8.59e-06	0.000179	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CAV1—ovarian cancer	6.92e-06	0.000144	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CG—ovarian cancer	6.3e-06	0.000131	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CD—ovarian cancer	5.54e-06	0.000115	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.83e-06	0.000101	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTEN—ovarian cancer	4.17e-06	8.69e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.94e-06	6.13e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AKT1—ovarian cancer	2.41e-06	5.01e-05	CbGpPWpGaD
